PRE official logo PRE
PRE 2-star rating from Upturn Advisory
Prenetics Global Ltd (PRE) company logo

Prenetics Global Ltd (PRE)

Prenetics Global Ltd (PRE) 2-star rating from Upturn Advisory
$14.86
Last Close (24-hour delay)
Profit since last BUY0%
upturn advisory logo
Consider higher Upturn Star rating
BUY since 1 day
  • BUY Advisory
  • SELL Advisory (Profit)
  • SELL Advisory (Loss)
  • Profit
  • Loss
  • Pass (Skip investing)
Upturn Stock price based on last close icon Stock price based on last close
*as per simulation
(see disclosures)
Time period over
  • ALL
  • 1Y
  • 1M
  • 1W

Upturn Advisory Summary

12/12/2025: PRE (2-star) has a low Upturn Star Rating. Not recommended to BUY.

Upturn Star Rating

Upturn 2 star rating for performance

Below Average Performance

These Stocks/ETFs, based on Upturn Advisory, often underperform the market, warranting careful consideration before investing.

Number of Analysts

1 star rating from financial analysts

1 Analysts rated it

Very few follow this stock; limited insights, higher-risk early investing.

1 Year Target Price $31

1 Year Target Price $31

Analysts Price Target For last 52 week
$31 Target price
52w Low $3.09
Current$14.86
52w High $17.99

Analysis of Past Performance

Type Stock
Historic Profit 44.81%
Avg. Invested days 25
Today’s Advisory Consider higher Upturn Star rating
Upturn Star Rating upturn star rating icon
Upturn Advisory Performance Upturn Advisory Performance icon 3.0
Stock Returns Performance Upturn Returns Performance icon 3.0
Upturn Profits based on simulation icon Profits based on simulation
Upturn last close icon Last Close 12/12/2025

Key Highlights

Company Size Small-Cap Stock
Market Capitalization 249.99M USD
Price to earnings Ratio -
1Y Target Price 31
Price to earnings Ratio -
1Y Target Price 31
Volume (30-day avg) 1
Beta 0.34
52 Weeks Range 3.09 - 17.99
Updated Date 12/13/2025
52 Weeks Range 3.09 - 17.99
Updated Date 12/13/2025
Dividends yield (FY) -
Basic EPS (TTM) -3.59

Analyzing Revenue: Products, Geography and Growth

Revenue by Geography

Geography revenue - Year on Year

Earnings Date

Report Date -
When -
Estimate -
Actual -

Profitability

Profit Margin -60.39%
Operating Margin (TTM) -26.17%

Management Effectiveness

Return on Assets (TTM) -14.78%
Return on Equity (TTM) -30.08%

Valuation

Trailing PE -
Forward PE -
Enterprise Value 228365431
Price to Sales(TTM) 3.24
Enterprise Value 228365431
Price to Sales(TTM) 3.24
Enterprise Value to Revenue 3.1
Enterprise Value to EBITDA 0.14
Shares Outstanding 15247465
Shares Floating 10710292
Shares Outstanding 15247465
Shares Floating 10710292
Percent Insiders 18.18
Percent Institutions 10.39

About Prenetics Global Ltd

Exchange NASDAQ
Headquaters -
IPO Launch date 2022-05-18
Co-Founder, Chairperson & CEO Mr. Sheng Wu Yeung
Sector Healthcare
Industry Diagnostics & Research
Full time employees 285
Full time employees 285

Prenetics Global Limited, a health sciences company, focuses on advancing consumer health in Hong Kong, the United States, and internationally. It sells health and wellness products under the IM8 brand name; and provides fulfillment and distribution services for sports nutrition products under the Europa brand. The company is also involved in the operation of CircleDNA, a consumer genetic testing brand that uses next-generation sequencing (NGS) technology to provide comprehensive insights into health, wellness, and genetic predispositions. Prenetics Global Limited was founded in 2014 and is headquartered in Quarry Bay, Hong Kong.